Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 078 764.9 |
96 | EP file number | EAKZ | 14 76 8317.1 |
86 | WO file number | WAKZ | PCT/US2014/022789 |
97 | EP publication number | EPN | 2970308 |
87 | WO publication number | WPN | 2014150276 |
54 | Designation/title | TI | VERBINDUNGEN UND VERWENDUNGEN DAVON ZUR MODULATION VON HÄMOGLOBIN |
51 | IPC main class | ICM (ICMV) | C07D 487/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07D 401/12 (2006.01), C07D 213/30 (2006.01), C07D 211/62 (2006.01), C07D 257/04 (2006.01), C07D 471/04 (2006.01), C07D 231/56 (2006.01), C07C 65/30 (2006.01), C07D 401/04 (2006.01), C07D 401/14 (2006.01), A61P 7/00 (2006.01), A61K 31/437 (2006.01), C07D 405/14 (2006.01), C07D 211/70 (2006.01), C07D 213/69 (2006.01), C07D 227/08 (2006.01), C07D 405/04 (2006.01), C07D 213/64 (2006.01), A61K 31/5375 (2006.01), A61P 7/06 (2006.01), A61P 9/10 (2006.01) |
22 | DE application date | DAT | Mar 10, 2014 |
96 | EP application date | EAT | Mar 10, 2014 |
86 | WO application date | WAT | Mar 10, 2014 |
43 | Date of first publication | OT | Sep 25, 2014 |
| Date of publication of grant | PET | Jul 14, 2021 |
71/73 | Applicant/owner | INH | Global Blood Therapeutics, Inc., South San Francisco, CA, US |
72 | Inventor | IN | METCALF, Brian W., South San Francisco, California 94080, US; LI, Zhe, South San Francisco, California 94080, US; XU, Qing, South San Francisco, California 94080, US; GWALTNEY, Stephen L., II., South San Francisco, California 94080, US; HARRIS, Jason R., South San Francisco, California 94080, US; YEE, Calvin W., South San Francisco, California 94080, US |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361905802 P Nov 18, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361905803 P Nov 18, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201313815770 Mar 15, 2013
|
| Due date | FT FG | Mar 31, 2026 Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document: EP000002970308 Searchable text:
EP000002970308 Original document:
EP000002970308B1 Searchable text:
EP000002970308B1 Original document:
WO002014150276 Searchable text:
WO002014150276 |
43 | Date of first publication | EVT | Sep 25, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Mar 4, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 14, 2025 (Show all update days)(Hide all update days)- Feb 14, 2025
- Sep 19, 2024
- Procedures: Procedure relating to PCT application, Publication of PCT application, 25.09.2014: deleted
- May 9, 2024; Apr 25, 2024; Apr 11, 2024; Feb 15, 2024; Jan 20, 2023; Jun 30, 2022; Jun 2, 2022; Jan 20, 2022; Aug 4, 2021; Jul 29, 2021; Jun 26, 2021; Jun 24, 2021; Mar 15, 2018
- Historical data not available for this/these date(s)
- Mar 4, 2016
- Date of the first transfer into DPMAregister
|